Ursolic acid: A promising therapeutic agent for metabolic dysfunction-associated steatotic liver disease via inhibition of SPP1-induced Th17 cell differentiation: Editorial on "Ursolic acid targets secreted phosphoprotein 1to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease"

被引：2
作者：
Kim, So Jung [1 ]
Hyun, Jeongeun [1 ]
机构：
[1] Dankook Univ, Dept Nanobiomed Sci, Dandea Ro 119, Cheonan 31116, South Korea
来源：
CLINICAL AND MOLECULAR HEPATOLOGY | 2024年 / 30卷 / 04期
关键词：
Metabolic dysfunction-associated steatotic liver disease; Ursolic acid; Secreted phosphoprotein 1; Helper T 17; HEPATIC STEATOSIS; OSTEOPONTIN; PROTECTS; FIBROSIS;
D O I：
10.3350/cmh.2024.0412
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：6
相关论文
共 20 条
[1]   The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Charlton, Michael ;
Cusi, Kenneth ;
Rinella, Mary ;
Harrison, Stephen A. ;
Brunt, Elizabeth M. ;
Sanyal, Arun J. .
HEPATOLOGY, 2018, 67 (01) :328-357
[2]   Serum Interleukin-8, Osteopontin, and Monocyte Chemoattractant Protein 1 Are Associated With Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease [J].
Glass, Oliver ;
Henao, Ricardo ;
Patel, Keyur ;
Guy, Cynthia D. ;
Gruss, Hans J. ;
Syn, Wing-Kin ;
Moylan, Cynthia A. ;
Streilein, Robert ;
Hall, Russell ;
Mac Diehl, Anna ;
Abdelmalek, Manal F. .
HEPATOLOGY COMMUNICATIONS, 2018, 2 (11) :1344-1355
[3]   Macrophage-derived Osteopontin (SPP1) Protects From Nonalcoholic Steatohepatitis [J].
Han, Hui ;
Ge, Xiaodong ;
Komakula, Sai Santosh Babu ;
Desert, Romain ;
Das, Sukanta ;
Song, Zhuolun ;
Chen, Wei ;
Athavale, Dipti ;
Gaskell, Harriet ;
Lantvit, Daniel ;
Guzman, Grace ;
Nieto, Natalia .
GASTROENTEROLOGY, 2023, 165 (01) :201-217
[4]   Lipid-injured hepatocytes release sOPN to improve macrophage migration via CD44 engagement and pFak-NFκB signaling [J].
Jiang, Xin ;
Zhang, Fan ;
Ji, Xueying ;
Dong, Fangyuan ;
Yu, Huiyuan ;
Xue, Mengjuan ;
Qiu, Yixuan ;
Yang, Fan ;
Hu, Xiaona ;
Bao, Zhijun .
CYTOKINE, 2021, 142
[5]   Osteopontin deficiency protects against obesity-induced hepatic steatosis and attenuates glucose production in mice [J].
Kiefer, F. W. ;
Neschen, S. ;
Pfau, B. ;
Legerer, B. ;
Neuhofer, A. ;
Kahle, M. ;
de Angelis, M. Hrabe ;
Schlederer, M. ;
Mair, M. ;
Kenner, L. ;
Plutzky, J. ;
Zeyda, M. ;
Stulnig, T. M. .
DIABETOLOGIA, 2011, 54 (08) :2132-2142
[6]   Increased hepatic and circulating chemokine and osteopontin expression occurs early in human NAFLD development [J].
Kriss, Michael ;
Golden-Mason, Lucy ;
Kaplan, Jeffrey ;
Mirshahi, Faridoddin ;
Setiawan, V. Wendy ;
Sanyal, Arun J. ;
Rosen, Hugo R. .
PLOS ONE, 2020, 15 (07)
[7]   Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma [J].
Liu, Lulu ;
Zhang, Ruyi ;
Deng, Jingwen ;
Dai, Xiaomeng ;
Zhu, Xudong ;
Fu, Qihan ;
Zhang, Hangyu ;
Tong, Zhou ;
Zhao, Peng ;
Fang, Weijia ;
Zheng, Yi ;
Bao, Xuanwen .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (01) :121-136
[8]   Osteopontin mediates macrophage chemotaxis via 4 and 9 integrins and survival via the 4 integrin [J].
Lund, Susan Amanda ;
Wilson, Carole L. ;
Raines, Elaine W. ;
Tang, Jingjing ;
Giachelli, Cecilia M. ;
Scatena, Marta .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2013, 114 (05) :1194-1202
[9]   The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression [J].
Schulien, Isabel ;
Hockenjos, Birgit ;
Schmitt-Graeff, Annette ;
Perdekamp, Markus Grosse ;
Follo, Marie ;
Thimme, Robert ;
Hasselblatt, Peter .
CELL DEATH AND DIFFERENTIATION, 2019, 26 (09) :1688-1699
[10]  
Schwabe RF, 2020, GASTROENTEROLOGY, V158, P1913, DOI 10.1053/j.gastro.2019.11.311
12